PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0442874|neuropathy |
| Sentences | 9 |
| PubMedID- 24599932 | Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel. |
| PubMedID- 23675348 | Similarly adjuvant chemotherapy in breast cancer survivors is associated with fatigue, neuropathy, cardiomyopathy, ovarian dysfunction, leukemia, and psychological distress (postma et al., 1995; partridge and ruddy, 2007; beadle et al., 2009; bowles et al., 2012). |
| PubMedID- 23204130 | Experimental design: a gwas of paclitaxel-induced cytotoxicity was conducted in 247 lcls from the hapmap project and compared with a gwas of sensory peripheral neuropathy in patients with breast cancer (n = 855) treated with paclitaxel in the cancer and leukemia group b (calgb) 40101 trial. |
| PubMedID- 26374076 | Correction: replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel-letter. |
| PubMedID- 26133776 | Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel--letter. |
| PubMedID- 22851566 | Therefore, we sought to determine whether neuropathy was associated with breast cancer recurrence in a clinical trial population who received adjuvant taxane therapy. |
| PubMedID- 26133777 | Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel--response. |
| PubMedID- 22584733 | Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: n-sas bc 02, a randomized clinical trial. |
| PubMedID- 25596818 | A phase ii randomized trial that will assess the effects of acupuncture in preventing dose reductions due to chemotherapy-induced peripheral neuropathy in patients with breast cancer is currently ongoing (clinicaltrials.gov identifier nct01881932). |
Page: 1